1. Home
  2. AEMD vs BDRX Comparison

AEMD vs BDRX Comparison

Compare AEMD & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AEMD
  • BDRX
  • Stock Information
  • Founded
  • AEMD 1984
  • BDRX 2000
  • Country
  • AEMD United States
  • BDRX United Kingdom
  • Employees
  • AEMD N/A
  • BDRX N/A
  • Industry
  • AEMD Medical/Dental Instruments
  • BDRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AEMD Health Care
  • BDRX Health Care
  • Exchange
  • AEMD Nasdaq
  • BDRX Nasdaq
  • Market Cap
  • AEMD 4.1M
  • BDRX 4.3M
  • IPO Year
  • AEMD N/A
  • BDRX N/A
  • Fundamental
  • Price
  • AEMD $1.14
  • BDRX $7.04
  • Analyst Decision
  • AEMD Buy
  • BDRX
  • Analyst Count
  • AEMD 2
  • BDRX 0
  • Target Price
  • AEMD $28.75
  • BDRX N/A
  • AVG Volume (30 Days)
  • AEMD 126.6K
  • BDRX 34.3K
  • Earning Date
  • AEMD 08-13-2025
  • BDRX 09-29-2025
  • Dividend Yield
  • AEMD N/A
  • BDRX N/A
  • EPS Growth
  • AEMD N/A
  • BDRX N/A
  • EPS
  • AEMD N/A
  • BDRX N/A
  • Revenue
  • AEMD N/A
  • BDRX N/A
  • Revenue This Year
  • AEMD N/A
  • BDRX N/A
  • Revenue Next Year
  • AEMD N/A
  • BDRX N/A
  • P/E Ratio
  • AEMD N/A
  • BDRX N/A
  • Revenue Growth
  • AEMD N/A
  • BDRX N/A
  • 52 Week Low
  • AEMD $1.09
  • BDRX $5.85
  • 52 Week High
  • AEMD $8.44
  • BDRX $163.10
  • Technical
  • Relative Strength Index (RSI)
  • AEMD 38.81
  • BDRX 36.90
  • Support Level
  • AEMD $1.09
  • BDRX $6.86
  • Resistance Level
  • AEMD $1.41
  • BDRX $7.25
  • Average True Range (ATR)
  • AEMD 0.09
  • BDRX 0.54
  • MACD
  • AEMD 0.02
  • BDRX 0.03
  • Stochastic Oscillator
  • AEMD 15.62
  • BDRX 38.98

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

About BDRX Biodexa Pharmaceuticals plc

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Share on Social Networks: